Prophase Labs Stock Investor Sentiment
| PRPH Stock | USD 5.16 0.26 5.31% |
Under 55% of ProPhase Labs' traders are presently thinking to get in. The analysis of overall sentiment of trading ProPhase Labs stock suggests that some investors are interested at this time. ProPhase Labs' investor sentiment overview provides quick insight into current market opportunities from investing in ProPhase Labs. The current market sentiment, together with ProPhase Labs' historical and current headlines, can help investors time the market. In addition, many technical investors use ProPhase Labs stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ProPhase Labs stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ProPhase daily returns and investor perception about the current price of ProPhase Labs as well as its diversification or hedging effects on your existing portfolios.
ProPhase |
ProPhase Labs Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ProPhase Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. That information is available publicly through ProPhase media outlets and privately through word of mouth or via ProPhase internal channels. However, regardless of the origin, that massive amount of ProPhase data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.
ProPhase Labs Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | ProPhase Labs nears launch of esophageal cancer diagnostic | 02/20/2024 |
2 | ProPhase Labs, Inc. Shares Could Be 29 percent Above Their Intrinsic Value Estimate | 03/01/2024 |
3 | ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives | 03/15/2024 |
4 | ProPhase Labs, Inc. Q4 2023 Earnings Call Transcript | 03/18/2024 |
5 | Acquisition by Jason Barr of 70000 shares of ProPhase Labs at 6.0 subject to Rule 16b-3 | 03/19/2024 |
6 | ProPhase Labs Stock Crosses Above 200 Day Moving Average of 4.69 - MarketBeat | 03/20/2024 |
7 | ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635 | 04/02/2024 |
8 | Strength Seen in Theravance Bio Can Its 7.6 percent Jump Turn into More Strength | 04/15/2024 |
9 | Acquisition by Louis Gleckel of 40000 shares of ProPhase Labs at 7.31 subject to Rule 16b-3 | 04/23/2024 |
Check out ProPhase Labs Hype Analysis, ProPhase Labs Correlation and ProPhase Labs Performance. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is ProPhase Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (0.98) | Revenue Per Share 2.579 | Quarterly Revenue Growth (0.84) | Return On Assets (0.15) |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.